Universe Pharmaceuticals INC (UPC)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Annual Financials
| Metric | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 40.1M | 32.3M | 23.0M | 17.9M |
| Gross Profit | 21.9M | 10.3M | 6.1M | 6.3M |
| Operating Income | -7.0M | -4.0M | -8.0M | -2.9M |
| Net Income | -7.9M | -6.6M | -8.7M | -3.7M |
| Diluted EPS | $-1,335.29 | $-1,089.21 | $-626.96 | $nan |